Allogene Therapeutics (ALLO) P/S US GAAP (year values) |
|||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | CAGR 5 years ? | |||
| P/S | ? | 17.8 | 0.00 | 0.00 | 18 861 | ||||
| Changes by years, y/y, % | -100% | +920.2% | |||||||
Allogene Therapeutics. P/S
Allogene Therapeutics. P/S, changes, %
Allogene Therapeutics (ALLO) P/S US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/S | ? | 147.5 | ||||||
| Changes by years, y/y, % | -100% | |||||||
| Changes by quarters, q/q, % | ||||||||